EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 5

Gentian root Gentiana lutea L.

Also called: yellow gentian, bitterwort, gentian, Gentianae radix

Gentian root comes from yellow gentian, a plant growing 1-2 m tall in alpine and sub-alpine pastures. Its intensely bitter root is used as a bitter tonic; the EU has a traditional-use monograph for loss of appetite and mild digestive complaints.

Category
Botanical
Part used
Root (dried)
Strongest evidence
C Limited
Native range
Native to the mountains of Europe east to western Türkiye (POWO: "European Mts. to W. Türkiye")
Reviewed
2026-10-29

Class 3 Limited studies in people. The 2018 EMA assessment states that controlled clinical trials of gentian root have not been performed; the human data are an open, uncontrolled study in 205 patients and small pharmacological studies in volunteers. A PubMed search found no later RCT of gentian alone. [1]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied2 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Gentian root does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Gentian root, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Dyspeptic symptoms in adultsCThe main gentian-only study was open and uncontrolled: 205 patients took a gentian dry extract for 15 days, with 68% average symptom improvement. EMA said the open design only supports plausibility. [1]
Saliva and gastric secretion (bitter-taste response)CIn a Latin-square study in 24 healthy volunteers, 2% gentian tincture increased salivary secretion over 30 minutes, similar to a citric acid control; older small studies reported increased saliva and gastric secretion. [1]
Loss of appetite and mild digestive disorders (EU traditional use)CThe EU monograph accepts these uses exclusively on the basis of long-standing use, not proof of efficacy from clinical trials. [2]

Main constituents: Bitter constituents (2-8%), mostly secoiridoid glycosides: mainly gentiopicroside, with a lower amount of amarogentin (0.025-0.4%), described as the most bitter substance known [1]; Xanthones (some gave positive Ames test results) [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Stated in the EU traditional-use monograph (2018), adults: 0.6-2 g root as an infusion 1-3 times daily (0.6-6 g/day), or 240 mg dry extract 2-3 times daily. [2]
  • Studied in an open study: 120 mg dry extract capsules, average 4.8 capsules/day, for 15 days. [1]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Safety during pregnancy and lactation has not been established; in the absence of sufficient data, use is not recommended.

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    None reported

    Medicines in general: EU monograph: none reported.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked. The profile notes other test results.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    EU HMPC traditional use (Revision 1, 20 November 2018), adults: 0.6-2 g comminuted root in 150 ml boiling water 1-3 times daily (0.6-6 g/day) …

    Details and sources
  • Poisonings attributed to gentian were mostly due to adulteration or mistaken use of white hellebore (Veratrum album), which is often mistaken for Gentiana lutea. [1]
  • No undesirable effects are known for the monograph preparations; use under 18 years and in pregnancy and lactation is not recommended because of lack of data. [2]
  • In the open study, adverse events (flatulence, soft stools, stomach cramps, nausea, headache) occurred in 2.4% of 205 patients. [1]
Quality

Identity, quality and standardization

  • Bitter-substance content depends on season, root age and altitude; roots must be dried directly after harvest to avoid fermentation that lowers extract content. [1]
  • The EU monograph specifies root material complying with the Ph. Eur. monograph (ref. 0392). [2]
Regulation

Regulatory status

  • US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for safety and labeling, and an NDI notification is required for certain new dietary ingredients. [3]
  • EU: HMPC herbal monograph (Revision 1, 2018) for traditional use in temporary loss of appetite and mild dyspeptic or gastrointestinal disorders. [2]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Gentiopicroside Secoiridoid glycoside (bitter principle) [P1]
  • Amarogentin Secoiridoid glycoside (bitter principle) [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming gentian root (Gentiana lutea) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. One NDI (368) names a multi-herb ingredient containing a different species, Gentiana macrophylla root. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of gentian root (Gentiana lutea) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
  • NTP technical reports list checked: no report on this plant. [P4]
  • EMA: tests on reproductive toxicity, genotoxicity and carcinogenicity have not been performed; some xanthones from Gentiana lutea gave positive Ames test results. [P5]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • Medicines in general: EU monograph: none reported. [P5]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • EMA assessment report (2018): Veratrum album has often been taken by mistake for Gentiana lutea, and most reported poisonings were due to adulteration or mistaken use of Veratrum album. [P1]

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each component that is a dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under (a)(1)(ii). [P6]
  • Botanical identity that excludes Veratrum album — Veratrum album is often mistaken for Gentiana lutea and accounts for most reported poisonings. [P1]
  • Compliance with the Ph. Eur. monograph for gentian root (0392) — Specified for the herbal substance in the EU HMPC monograph. [P5]

Supply and conservation

  • EMA (2018): the plant is under wildlife protection, so it is cultivated for plant production mostly in Germany and France. [P1]

Absorption in people

  • EMA (2018): no pharmacokinetic data were found for the herbal substance or herbal preparations; the available data (rats, human intestinal bacteria in vitro) concern the constituent gentiopicroside. [P1]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • EU HMPC traditional use (Revision 1, 20 November 2018), adults: 0.6-2 g comminuted root in 150 ml boiling water 1-3 times daily (0.6-6 g/day); dry extract 240 mg 2-3 times daily (480-720 mg/day); liquid extract 2-4 g/day; tincture 1-3 ml/day. [P5]

Pregnancy and breastfeeding

  • Safety during pregnancy and lactation has not been established; in the absence of sufficient data, use is not recommended. [P5]

Sources for this profile

  1. EMA HMPC. Assessment report on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607863/2017, final, 20 November 2018), 2018-11-20. ema.europa.eu
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs. List of Classifications (1,060 agents, Volumes 1-142; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  4. National Toxicology Program (NIEHS). Technical Reports series list (607 reports; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  5. EMA HMPC. European Union herbal monograph on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607861/2017, final, 20 November 2018), 2018-11-20. ema.europa.eu
  6. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources

Sources

  1. EMA HMPC. Assessment report on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607863/2017, final, 20 November 2018), 2018-11-20. ema.europa.eu
  2. EMA HMPC. European Union herbal monograph on Gentiana lutea L., radix, Revision 1 (EMA/HMPC/607861/2017, final, 20 November 2018), 2018-11-20. ema.europa.eu
  3. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  4. Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Gentiana lutea L.: accepted name and native range as recorded in WCVP, the taxonomic index of POWO (WCVP Darwin Core archive, GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, published 2026-06-04; read 2026-10-29), 2026-06-04. powo.science.kew.org
  5. Ponticelli M, et al. The healing bitterness of Gentiana lutea L., phytochemistry and biological activities: a systematic review. Phytochemistry 2023;206:113518 (PMID 36423749), 2023-02. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.